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1. SUMMARY 
In this work, the synthesis of several platinum (II) cyclometallated compounds with bidentate 
ligands type [C,N] has been reported.  
In order to carry out this synthesis, compound K2[PtCl4] has been used to prepare the metal 
agent (1a) used in all cyclometallation reactions. One amine (2a) and three different imines (2b-
2c), previously synthesized from amine 2a and the corresponding aldehyde, have been used as 
ligands.  
These ligands have been reacted with compound 1a in toluene or in methanol to inquire 
which of these solvents is more optimal for the cyclometallation, thus obtaining cyclometallated 
compounds (3a-3d). The expected isomer for this synthesis is the endo configuration but 
depending on the solvent and the imine used different isomers such as exo configuration or 
even cyclometallated compounds with metallacycles containing more than five members might 
be obtained. 
The latter were subsequently reacted with triphenylphosphane to form the corresponding 
derivatives (4a-4d) where the number of isomers has been reduced due to the stability given to 
the compound by triphenylphosphane. 
The nature of the synthesised compounds has been studied by proton nuclear magnetic 





Keywords: Cyclometallated compounds, platinum, bidentate ligands, nuclear magnetic 
resonance spectroscopy, mass spectrometry, synthesis.
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2. RESUM 
En aquest treball s’ha dut a terme la síntesi de diversos compostos ciclometal·lats de 
platí(II) amb lligands bidentats de tipus [C,N].  
Per tal de dur a terme aquesta síntesi, s’ha utilitzat el compost K2[PtCl4] per a formar l’agent 
metal·lant (1a) utilitzat en totes les reaccions de ciclometal·lació. Com a lligands s’han utilitzat 
una amina (2a) i tres imines diferents (2b-2d) preparades a partir de l’amina 2a i l’aldehid 
corresponent.  
Aquests lligands s’han fet reaccionar amb el compost 1a en toluè i en metanol per tal de 
distingir quin d’aquests dissolvents és més òptim per a la ciclometal·lació, obtenint així els 
compostos ciclometal·lats (3a-3d). L’isòmer esperat per a aquesta síntesi és la configuració 
endo, però segons el dissolvent i la imina utilitzats es poden obtenir diferents isòmers com la 
configuració exo o anells de més de 5 àtoms.  
Posteriorment, aquests últims s’han fet reaccionar amb trifenilfosfana formant els 
corresponents derivats (4a-4d) on la quantitat d’isòmers s’ha vist reduïda per l’estabilitat que la 
trifenilfosfana dona al compost.  
S’ha comprovat la naturalesa dels compostos formats mitjançant espectroscòpia de 
ressonància magnètica nuclear de protó i alguns compostos també s’han estudiat per 




Paraules clau: Compostos ciclometal·lats, platí, lligands bidentats, espectroscòpia de 
ressonància magnètica nuclear, espectrometria de masses, síntesi.  
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3. INTRODUCTION 
 In the 1960s, a new platinum(II) compound with anticancer properties was discovered, 
cisplatin.1 Cisplatin is useful for the treatment of testicular cancer, among others.2 Other 
compounds that are usually used for clinical application are carboplatin and oxaliplatin.1–3 These 
compounds kill cancer cells by cross-linking DNA and inhibiting transcription. When one of 
these compounds enters a cell it loses one or both chloride ligands, forming an aqua-complex 
that is very electrophilic. This complex can react easily with the purine bases of nucleic acids, 
which are strongly nucleophilic. The reaction of the complex with the purine base forms a Pt-
adduct that is capable of distorting and bending the DNA structure.2,3 However, it induces some 
toxic side effects such as nephrotoxicity, neurotoxicity and, sometimes, it can induce a 









These kind of potential anticancer compounds need to have some different types of ligands 
in their own structure to achieve their function. First, ligands L are non-leaving groups, which are 
generally nitrogen donors. Their function is to be retained in the final platinum-DNA adduct. 
Secondly, ligands X are leaving groups. They are lost when the complex enters the cell to allow 
coordination to DNA. Finally, ligands R, which are only present in the axial position of platinum 
(IV) compounds, can modulate the properties of this compounds.2,6,7 
 
 
Figure 1. Chemical structure of clinically approved platinum antitumor complexes. 
 







Cyclometallated compounds have also been studied as potential anticancer agents, where the 
cyclometallated moiety will be retained as indicated above for ligands L. These platinum 
cyclometallated compounds contain a σ(C-Pt) bond, which increases the stability of the 
complex, thus being able to reach the cell without modifications in their structure and 
behaviour.7,8 In the preparation of cyclometallated compounds it is common to use a [C,N] 
bidentate ligand as a non-leaving group (L). These are of great interest and the most studied 
ones, but also some others compounds with [C,N,N’] or [N,C,N] tridentate ligands exist, whose 
stability is increased due to the presence of another N-donor atom.7–9 
3.1. MECHANISMS OF THE CYCLOMETALLATION  
The cyclometallation reaction can be described in two consecutive steps; i) coordination of 













Figure 2. General structure of platinum(II) (1) or platinum(IV) (2) anticancer complexes. 
 
 
Figure 3. Electrophilic substitution mechanism for C-H activation. 
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The second step can happen through two different mechanisms: 1) oxidative addition, 
where the oxidation of platinum(II) to platinum(IV) is followed by an immediate reductive 
elimination to the initial oxidation state 2) electrophilic substitution, where an aromatic carbon 
goes through an electrophilic aromatic substitution of the H for a platinum atom, forming a C-Pt 
bond. The presence of a base is necessary for the elimination of the aromatic protons.2,7 The 
latter is the mechanism taking place in the reactions studied in this work. 
3.2. ISOMERISM STUDY 
This project is focused on finding procedures that allow the synthesis of new 
cyclometallated platinum(II) compounds that contain imine ligands and are potentially useful for 
anticancer therapy. The most widely studied examples are platinum(II) compounds where C-H 
activation takes places at phenyl ortho positions to produce five-membered cyclometallated 
compounds. It is possible that, occasionally, a six-membered cyclometallated or even a seven-
membered cyclometallated compound in the case of a toluene insertion are produced, but these 
results are uncommon. The most stable compounds are the five-membered metallacycles.10  
Within five-member metallacycles, several isomers such as endo-/exo- exist. When the 
metallacycles contain the C=N moiety it is called as endo- and when it does not contain the C=N 
moiety it is called as exo-. In addition, switching the X and Y ligands that act as a leaving group 
gives rise to configurational isomers. It is known that for several cycloplatinated compounds the 











Figure 4. Endo- and exo- isomers, X = Y = Cl, SOMe2. 
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In addition, when the exo isomer is obtained, the imine ligand can be present in either Z or E 
configuration. It depends on the position of the aromatic cycle attached to the C=N bond 









Since several cyclometallated platinum(II) compounds derived from optically active amines 
were found to be effective against several cancer cell lines, this work was carried out with the 
aim of exploring the possibility to expand this family of potential antitumor agents.3 The reaction 
of each compound with a platinum substrate was carried out following two different procedures 











Figure 5. Cis- (Z) and trans- (E) isomers, X = Y = Cl, SOMe2 
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4. OBJECTIVES 
The aims of this work are: 
- The synthesis of new cyclometallated platinum(II) compounds containing a 
bidentate [C,N] ligand: 
[PtCl{NH2CH(CH3)C10H6}{SOMe2}] (3a)  
[PtCl{(4-ClC6H3)CHNCH(CH3)C10H7}{SOMe2}] (3b)  
[PtCl{(2,6-Cl2C6H3)CHNCH(CH3)C10H6}{SOMe2}] (3c) 
[PtCl{(C10H6)CH(CH3)NCHC10H7}{SOMe2}] (3d) 
- The study of the obtained isomers for all the compounds synthesized depending 
on the solvent used in the cyclometallation reaction.  
- The study of the reactivity of the obtained cyclometallated compounds in front of 
triphenylphosphane ligand. 
- The characterization of the new cyclometallated platinum(II) compounds by mass 
spectrometry and nuclear magnetic resonance spectroscopy. 
- The comparison of the obtained results to determine which solvent is the most 
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5. RESULTS AND DISCUSSION 
Due to the multiple possible isomers that can be obtained as result of the performed 





the type of 
compound  
Letter to list 
the 
compounds  
Endo- (A) or 
exo- (B) 
Cis- (Z) or 
trans- (E) in 
ligand or in 
exo- isomers 
Metal agent 1 a - - 
Ligand 2 a, b, c, d - Z/E 
Cycloplatinated 
compounds 
3 a, b, c, d A/B Z/E 
Phosphane 
derivates 
4 a, b, c, d A/B Z/E 
Table 1. Scheme for tagging compounds. 
5.1. SYNTHESIS OF STARTING MATERIALS  
5.1.1. Synthesis of platinum (II) precursor 
Cis-[PtCl2{SO(Me)2}2] (1a) was synthesized following the method reported in the literature.14 
K2[PtCl4] is commonly used as an initial reagent for the synthesis of 1a.15 The reaction of 
several neutral ligands L with 1a gives the platinum(II) compounds [PtCl2L2]. In this project only 
DMSO (SOMe2) was used as ligand L. The obtained cis-[PtCl2{SO(Me)2}2] was used as a 
metallating agent to prepare compounds 3a, 3b, 3c and 3d. Compound 1a was characterized 








Figure 6. Synthesis of the metalling agent cis-[ 2]:  PtCl2{SO(Me)2}
(1) water, 3 h, r.t.. 
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5.2. SYNTHESIS OF IMINES 
5.2.1. Synthesis of (4-ClC6H4)CHNCH(CH3)C10H7 (2b) 
The synthesis of (R)-1-(4-chlorophenyl)-N-(1-(naphthalen-1-yl)ethyl)methanimine (2b) was 
carried out following the method reported in the literature.13,16 This ligand was synthesized from 
R-(+)-1-(1-naphtyl) ethyl)amine (2a) and 4-chlorobenzaldehyde in refluxing ethanol for 2 hours. 
Compound 2b was characterized by 1H-NMR spectroscopy. The sharpness of the 1H-NMR 
spectroscopy allowed to assume that only the more stable isomer of the imine was obtained, 
which displays an E- configuration around the C=N bond.15 It could be observed the appearance 
of the characteristic iminic peak which proves its correct synthesis. It could also be clearly 
observed a quadruplet from CH(CH3) due to coupling with the CH3 group which appears as a 









5.2.2. Synthesis of (2,6-Cl2C6H3)CHNCH(CH3)C10H7 (2c) 
The synthesis of (R)-1-(2,6-dichlorophenyl)-N-(1-(napthalen-1-yl)ethyl)methanimine (2c) 
was carried out following the literature.13,17 This ligand was synthesized from amine 2a and 2,6-
dichlorobenzaldehyde in refluxing ethanol for 2 hours. Characterisation by 1H-NMR 
spectroscopy resulted in concordance with the literature.17 Imine 2c was obtained as a single 
isomer, for which the most stable is E-configuration around the C=N bond. As in imine 2b it 





Figure 7. Synthesis of imine 2b: (1) ethanol, refluxing 3h. 
 










5.2.3. Synthesis of (C10H7)CHNCH(CH3)C10H7 (2d)  
The synthesis of (R)-1-(napthalen-1-yl)-N-(1-(napthalen-1-yl)ethyl)methanimine (2d) has 
been previously reported and it was carried out following the literature.13 This ligand was 
synthesized from 2a and 1-naphtaldehyde in refluxing ethanol for 2 hours. Compound 2d was 
characterized by 1H-NMR spectroscopy and compared with the literature.13 It was obtained as 
the most stable isomer with an E-configuration around the iminic bond. As well as for imines 2b 



















Figure 9. Synthesis of imine 2d: (1) ethanol, refluxing 3h. 
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5.3. SYNTHESIS OF CYCLOPLATINATED COMPOUNDS 
5.3.1. Synthesis of [PtCl{NH2CH(CH3)C10H6}{SOMe2}] (3a) 
The synthesis of compound 3a has been previously reported.16 For the study of the reaction 
of amine 2a, compound 1a and sodium acetate two different procedures were used. Toluene 
with a small amount of methanol at 90 ºC was used as a solvent in one procedure (1) and only 
methanol at 65 ºC was used in the other (2). Then, the first procedure was performed over the 
boiling point for the small amount of methanol but not at enough temperature for the reflux of 
toluene, as the metal agent 1a may be reduced to metallic platinum at temperatures above 
90ºC. Even so, quite platinum precipitated due to its reduction. Compound 3a was characterized 
by 1H-NMR spectroscopy and compared with that previously reported in the literature.16  
(1): It could be observed the characteristic peaks of the CH(CH3) quadruplet, in addition to 
the extra peaks of SOMe2 with Pt satellites.  










5.3.2. Synthesis of [PtCl{(4-ClC6H3)CHNCH(CH3)C10H7}{SOMe2}] (3b) 
For the synthesis of cyclometallated compound 3b the metal agent 1a, the ligand 2b, and 
sodium acetate were used. To try to avoid the platinum reduction, the temperature in the first 
procedure was decreased to 85 ºC, while the other conditions remained unchanged. Compound 
3b was characterised by 1H-NMR spectroscopy and mass spectrometry.  
Figure 10. Synthesis of compound 3a:  
(1) toluene/MeOH, CH3COONa , 48h, 90 ºC.  
(2) MeOH, CH3COONa, 48h, 65 ºC. 
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(1): It could be observed a mixture of compounds even though, as previously said, the most 
stable isomer for cyclometallated compounds is the endo- form (3bA).11–13 Firstly, the 
characteristic peak of an aldehyde at approximately 10 ppm at the 1H-NMR spectra was 
observed. It was confirmed by mass spectrometry, where it showed clearly a peak with the 
exact mass of 2b. This is due to the hydrolysis of imine to aldehyde and resulting to the 
synthesis of 3a instead. The 1H-NMR spectra of 3b was compared with 3a and observed 
approximately the same spectra in addition to the aldehyde protons.  
The synthesis was repeated in freshly distilled toluene. Thanks to the spectrum results and 
compared with the literature it was determined that the major compound was the endo- isomer, 
(3bA). This is due to the presence of two signals in the 6.99-6.89 ppm range that can be 
assigned to (Hi) and (Hi’) coupling in an A-B system. The signal of (Hi’) corresponds to a doublet 
of doublet as it is coupled with the iminic proton (Hh) in cis position, while (Hi) displays only a 
doublet.  
(2): It was also observed the hydrolysis of imine to aldehyde in this procedure. It appeared 
the characteristic peak of the aldehyde at approximately 10 ppm at the 1H-NMR spectra. It was 
also confirmed by mass spectrometry, where it showed clearly the mass of 2b. The 1H-NMR 
spectra confirmed the hydrolysis by comparison with 3a. The synthesis was repeated, and it 













Figure 11. Synthesis of compound 3b:  
(1) toluene with MeOH, CH3COONa, 48h, 85 ºC.  
(2) MeOH, CH3COONa, 48h, 65 ºC. 
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To check if the hydrolysis is due to the presence of platinum or to the solvents, a blank 
experiment was performed. Imine 2b was kept stirring in the same reaction conditions without 
adding the metal agent. Then the imine was characterized by 1H-NMR spectroscopy and it was 
observed that it had not hydrolysed. So, it was determined that the solvent was not the problem, 
but it is the coordination of the imine ligand to platinum which facilitates the hydrolysis with 
adventitious water contained in the solvent. 
5.3.3. Synthesis of [PtCl{(2,6-Cl2C6H3)CHNCH(CH3)C10H6}{SOMe2}] (3c) 
For the synthesis of cyclometallated compound 3c, compound 1a, ligand 2c and sodium 
acetate were used. In this reaction, the same conditions as for compound 3b were used in both 
procedures. Compound 3c was characterized by 1H-NMR spectroscopy and mass 
spectrometry. For this five-membered cyclometallated compound only the exo- isomer (3cBE) 
can be synthetized because it is impossible to obtain the endo- form due to both ortho- positions 
being occupied by chloride atoms. 
(1): It could be observed a mixture of compounds due to the large number of signals 
appearing in the 1H-NMR spectrum. Thanks to the mass spectrum it could be determined that a 
toluene insertion had happened, thus synthesizing, along with other compounds including 
3cBE, a seven-member cyclometallated compound which includes the endo- form (3cA’), that is 
more stable.11–13 
(2): Compound 3cBE was characterized by 1H-NMR spectroscopy. It could be observed the 
characteristic iminic peak with satellites due to the coupling with platinum, which proves the 
correct synthesis of this compound. It could also be clearly observed a quadruplet from CH(CH3) 
due to coupling with the CH3 group which appears as a doublet. It was compared with those 




















5.3.4. Synthesis of [PtCl{(C10H6)CH(CH3)NCHC10H7}{SOMe2}] (3d) 
For the synthesis of cyclometallated compound 3d compound 1a, ligand 2d and sodium 
acetate were used. To try to avoid the hydrolysis of the imine, dry freshly distilled toluene was 
used. All the other conditions were the same for both procedures as previously described. 
Compound 3d was characterized by 1H-NMR spectroscopy and mass spectrometry and 
compared with literature13. To try to understand the 1H-NMR spectra of (1) it was necessary to 
determine first the (2) 1H-NMR spectra. 
(2): A mixture of compounds could be observed, where the two major compounds had a 
ratio of 3:1 (3dBZ:3dBE). It was possible to determine the nature of these compounds thanks to 
the 1H-NMR spectra, where the coupling constants of the iminic satellites by coupling with 
platinum were approximately 50 ppm. That means the two major compounds are the exo- 
isomers. The range where the iminic proton appears in the 1H-NMR spectra was useful to 
identify which exo- isomer was the more abundant. It is known that in the trans- isomer, the 
iminic proton is much more downfield-shifted and it can appear in the 10 ppm range. Meanwhile, 
the iminic proton of the cis- isomer is  upfield-shifted. It can even appear in the aromatic zone 
overlapping other protons but identifiable by its characteristic satellite peaks from coupling with 
platinum.12 
 
Figure 12. Synthesis of compounds 3c:  
(1) toluene with MeOH, CH3COONa, 48h, 85 ºC.  
(2) MeOH, CH3COONa, 48h, 65 ºC. 
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(1): It was a mixture of compounds. It was observed a major compound that matches with 
the minor compound of (2) comparing the 1H-NMR spectra. It is known that the most stable 
isomer should be formed at the highest temperature. So, it was possible to determine that the 














5.4. SYNTHESIS OF TRIPHENYLPHOSPHANE DERIVATIVES 
5.4.1. Synthesis of [PtCl{NH2CH(CH3)C10H6}{PPh3}] (4a)  
For the synthesis of [PtCl{NH2CH(CH3)C10H6}{PPh3}] (4a) the cyclometallated compound 3a 
and triphenylphosphane were reacted in acetone for 2 hours at room temperature. Compound 
4a was characterized by 1H-NMR and 31P-NMR spectroscopy and mass spectrometry and 
compared with the literature.18,19 Thanks to the 1H-NMR it could be observed the characteristic 
quadruplet peak of CH(CH3). It could be observed too that the SOMe2 had disappeared and a 
lot of signals in the aromatic zone that belong to the protons form triphenylphosphane appeared. 
Thanks to the mass spectrum it could be determined that the aimed compound was 
synthesized. 
An assay was done with an excess of triphenylphosphane and the expected product 
[Pt{NH2CH(CH3)C10H6}{PPh3}2]Cl (4a’) was characterized by 1H-NMR and 31P-NMR 
 
Figure 13. Synthesis of compound 3d major isomers:  
(1) toluene with MeOH, CH3COONa, 48h, 85 ºC.  
(2) MeOH, CH3COONa, 48h, 65 ºC. 
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spectroscopy and mass spectrometry. Although the 1H-NMR it was not useful due to the low 
quality of the spectra it could be determined that two triphenylphosphane molecules instead of 
one had reacted thanks to the 31P-NMR spectrum. It is known that the phosphorus in trans- 
position to the N-donor has a coupling constant of approximately 4000 Hz and the one in cis- 






5.4.2. Synthesis of [PtCl{(4-ClC6H3)CHNCH(CH3)C10H7}{PPh3}] (4b)  
For the synthesis of [PtCl{(4-ClC6H3)CHNCH(CH3)C10H7}{PPh3}] (4b) the cyclometallated 
compound 3b and triphenylphosphane were reacted in acetone for 2 hours at room 
temperature. Compound 4b was characterized by 1H-NMR and 31P-NMR spectroscopy and 
mass spectrometry and compared with the literature.18,19 Only 31P-NMR was useful to determine 
the compound, where it could be observed a minor compound (4b) at 23.20 ppm and a major 
compound at 14.29 ppm identified as [PtCl2(PPh3)2].18 The de-coordination of the 
cyclometallated ligand explains the complexity of the 1H-NMR spectrum and the impossibility to 








Figure 14. Synthesis of compound 4a:  
(1) PPh3, acetone, 2h, r.t. 
 
 
Figure 15. Synthesis of compound 4b:  
(1) PPh3, acetone, 2h, r.t. 
 





5.4.3. Synthesis of [PtCl{(2,6-Cl2C6H3)CHNCH(CH3)C10H6}{PPh3}] (4c)  
For the synthesis of  [PtCl{(2,6-Cl2C6H3)CHNCH(CH3)C10H6}{PPh3}] (4c) the cyclometallated 
compound 3c and triphenylphosphane were reacted in acetone for 2 hours at room 
temperature. Compound 4c was characterized by 1H-NMR and 31P-NMR spectroscopy and 
mass spectrometry and compared with the literature.18,19 It could be observed the iminic peak 
and the characteristic quadruplet in the 1H-NMR spectra which means the aim product has 
formed. By 31P-NMR spectra it could be observed a mixture of compounds where the aimed 
product appears at 21.83 ppm as the major compound followed by [PtCl2(PPh3)2], which 






5.4.4. Synthesis of [PtCl{(C10H6)CH(CH3)NCHC10H7}{PPh3}] (4d)  
For the synthesis of [PtCl{(C10H6)CH(CH3)NCHC10H7}{PPh3}] (4d) the cyclometallated 
compound 3d and triphenylphosphane were reacted in acetone for 2 hours at room 
temperature. Compound 4d was characterized by 1H-NMR and 31P-NMR spectroscopy and 
mass spectrometry and compared with the literature.18,19 The solid obtained was yellow 
although these phosphane derivatives are usually white. In the 31P-NMR it could be observed 
that the aimed product was not formed, only OPPh3 and [PtCl2(PPh3)2] arising from the de-
coordination of the cyclometallated ligand were observed. The formation of OPPh3 probably is 
due to an excess of triphenylphosphane that was oxidized under the reaction conditions. 
Thanks to the mass spectra it could be observed that the aimed product was formed, but it was 
not possible to determine by NMR due to its low yield. 
 
Figure 16. Synthesis of compound 4c:  
(1) PPh3, acetone, 2h, r.t. 
 




























Figure 17. Synthesis of compound 4d:  
(1) PPh3, acetone, 2h, r.t. 
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6. EXPERIMENTAL SECTION 
6.1. REAGENTS AND SOLVENTS 
All reagents and solvents that have been used are from a commercial origin. Dry toluene 
was obtained from a Pure Solv. solvent dispenser.  
6.2. EQUIPMENT AND TECHNIQUES 
The techniques and equipment used to characterize all compounds were: 
- NMR spectra were registered at the “Unitat de RMN” of Universitat de Barcelona, by 
using the spectrometers Mercury (1H, 400.0 MHz) and Bruker 400 (31P-{1H}, 161.95MHz). The 
values of coupling constants (J) are given in Hz, and the chemical shift (δ) values are given in 
ppm relative to TMS for 1H and 85% H3PO4 for 31P. 
- ESI(+)-MS spectra were carried out at “Unitat d’Espectrometria de Masses de la 
Facultat de Química, Centres Científics i Tecnològics de la Universitat de Barcelona 
(CCiTUB)” by using an LC/MSD-TOF spectrometer and H2O:CH3CN (1:1) as solvent. 
6.3. PREPARATION AND CHARACTERIZATION OF COMPOUNDS 
The reported compounds were synthesized following the procedures reported in the 
literature, and were checked by 1H-NMR spectroscopy and MS spectrometry. Compounds 2b, 
2c, 2d, 3a, 3b, 3c, 3d, 4a, 4b, 4c and 4d, were prepared as detailed below.  
Characterization data are given for the major compounds obtained. 
6.3.1. Preparation of the precursors 
Cis-[PtCl2{SOMe2}]2 (1a)3,14 was obtained from 2.47 g (6.0 mmol) of K2[PtCl4] in 20 mL of 
water and 3 mL (42.2 mmol) of dimethylsulfoxide (DMSO). The mixture was stirred at room 
temperature for 4 hours. During the stirring a pale-yellow precipitate was formed. The solid was 
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filtered and dried under vacuum and washed several times with 5 mL of water, 5 mL of ethanol 
and 5 mL of diethyl ether. Yield: 2.36 g (94%).  
 
 
Pale-yellow solid.  
1H NMR (400 MHz, CDCl3) δ 3.54 [d, 3J (Ha-Pt) = 20.6 Hz, 1Ha]. 
 
 
R-(+)-1-(1-naphtyl) ethyl)amine (2a) was commercially available. 
 
Orange liquid.  
1H NMR (400 MHz, CDCl3) δ 8.12 [d, 3J (Hd-Hb) = 8.3 Hz, 1Hd]; 7.85 [dd, 3J 
(He-Hb) = 8.0,  3J (He-Hd) = 2.0 Hz, 1He]; 7.73 [d, 3J (Ha-Hb) = 8.2 Hz, 1Ha]; 
7.63 [d, 3J (Hc-Hb) = 7.1 Hz, 1Hc]; 7.56 – 7.42 [m, 3Hb]; 4.93 [q, 3J (Hf-Hg) = 6.6 
Hz, 1Hf]; 1.53 [d, 3J (Hg-Hf) = 6.6 Hz, 3Hg]. 
 
 
(R)-1-(4-chlorophenyl)-N-(1-(naphthalen-1-yl)ethyl)methanimine (2b)13,20,21 was obtained 
from 0.51 g (3.55 mmol) of 4-chloro-benzaldehyde and 0.61 g (3.55 mmol) of R-(+)-1-(1-naphtyl) 
ethylamine (2a) in 30 mL of ethanol. The mixture was stirred under reflux for 3 hours to give an 
orange solution. The solvents were removed using a rotatory evaporator and a brown solid was 
formed. To remove the solvents completely the solid was dried under vacuum. Yield: 0.73 g 
(70%). 
 
White solid. 2bE 
1H NMR (400 MHz, CDCl3) δ 8.38 [s, 1Hh]; 8.23 [d, 3J (Hd-Hb) = 8.4 
Hz, 1Hd]; 7.91 – 7.84 [d, 3J (He-Hb) = 8.0 Hz, 1He]; 7.78 [d, 3J (Ha-Hb) = 
7.6 Hz, 1Ha]; 7.74 [m, 3Hj,c], 7.57 – 7.43 [m, 3Hb], 7.38 [d, 3J (Hi-Hj) = 
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(R)-1-(2,6-dichlorophenyl)-N-(1-(napthalen-1-yl)ethyl)methanimine (2c)13,17,20,21 was 
obtained from 0.51 g (2.86 mmol) of 2,6-dichloro-benzaldehyde and 0.49 g (2.86 mmol) of 2a in 
30 mL of ethanol. The mixture was stirred under reflux for 3 hours to give an orange solution. 
The solvents were removed with a rotatory evaporator and an orange solid was formed. To 
remove the solvents completely the solid was dried under vacuum. Yield: 0.50 g (53%). 
 
Orange solid. 2cE 
1H NMR (400 MHz, CDCl3) δ 8.56 [s, 1Hh], 8.22 [d, 3J(Hd-Hb) = 8.6 
Hz, 1Hd], 7.88 [d, 3J (He-Hb) = 8.55 Hz, 1He], 7.84 [d, 3J (Ha-Hb) = 7.3 
Hz, 1Ha], 7.78 [d, 3J (Hc-Hb) = 8.2 Hz, 1Hc], 7.58 – 7.43 [m, 3Hb], 7.36 
– 7.16 [m, 3Hj,i], 5.51 [q, 3J (Hf-Hg) = 6.7 Hz, 1Hf], 1.80 [d, 3J (Hg-Hf) = 
6.7 Hz, 3Hg]. 
 
 
(R)-1-(napthalen-1-yl)-N-(1-(napthalen-1-yl)ethyl)methanimine (2d)13,20,21 was obtained 
from 0.49 g (3.2 mmol) of 1-napthaldehyde and 0.55 g (3.2 mmol) of 2a in 30 mL of ethanol. 
The mixture was stirred at reflux for 3 hours to give an orange solution. The solvents were 
removed with a rotatory evaporator and a brown solid was formed. To remove the solvents 
completely the solid was dried under vacuum. Yield: 0.71 g (71%). 
 
Brown solid. 2dE 
1H NMR (400 MHz CDCl3) δ 9.09 [s, 1Hh], 9.03 [d, 3J (Hk-Hj) = 
8.6Hz, 1Hk], 8.36 [d, 3J (Hd-Hb) = 8.5 Hz, 1Hd], 7.97 – 7.86 [m, 
5Ha,e,i,l,m], 7.79 [d, 3J (Hc-Hb) = 8.3Hz, 1Hc], 7.65 – 7.46 [m, 





6.3.2. Preparation of cyclometallated platinum (II) compounds 
[PtCl{NH2CH(CH3)C10H6}{SOMe2}] (3a)12,16 was obtained by different procedures, following 
the literature. 
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Procedure (1): Compound 3a was obtained from 150 mg (0.355 mmol) of compound 1a, 61 
mg (0.356 mmol) of compound 2a and 29 mg (0.36 mmol) of sodium acetate previously 
dissolved in 2 mL of MeOH and 25 mL of toluene as solvent. The mixture was firstly purged 
under nitrogen. In the same atmosphere the mixture was heated and stirred at 90 ºC for 48 
hours, using a magnetic stirrer equipped with a digital thermometer to control the temperature. 
The obtained mixture was filtered, and the solvent was removed in a rotatory evaporator. The 
solid obtained was dissolved in 1 mL of 1:1 MeOH/CH2Cl2 and the solution was kept for 24 
hours in the freezer. The obtained precipitate was filtered and dried under vacuum. Yield: 80 mg 
(47%). 
Procedure (2): Compound 3a was obtained from 151 mg (0.357 mmol) of compound 1a, 61 
mg (0.356 mmol) of compound 2a and 29 mg (0.365 mmol) of sodium acetate previously 
dissolved in 25 mL of MeOH. The mixture was firstly purged in nitrogen atmosphere. In the 
same atmosphere the mixture was heated and stirred at 65 ºC for 48 hours, using a magnetic 
stirrer equipped with a digital thermometer to control the temperature. The obtained mixture was 
filtered, and the solvent was removed with a rotatory evaporator. The solid was dissolved in 
1mL of CH2Cl2 and kept in the freezer for 24 hours. The obtained precipitated was filtered and 
dried under vacuum. Yield: 34 mg (17%). 
 
White solid.  
1H NMR (400 MHz, CDCl3) δ 8.13 [d, 3J (Hh-Hf) = 8.6 Hz, 3J (Hh-Pt) = 
42.20 Hz, 1Hh], 7.79 – 7.71 [m, 2Hd,e], 7.53 [d, J (Ha-Hb) = 8.6 Hz, 
1Ha], 7.51– 7.44 [m, 1Hc], 7.39 – 7.28 [m, 2Hb], 5.10 [p, J (Hg-Hf) = 
6.3 Hz, 1Hg], 3.47 [s, 3J (Hi-Pt) = 23.92 Hz, 3Hi], 3.41 [s, 3J (Hj-Pt) = 
22.4 Hz, 3Hj], 1.77 [d, J (Hf-Hg) = 6.5 Hz, 3Hf]. 
 
  
[PtCl{(4-ClC6H3)CHNCH(CH3)C10H7}{SOMe2}] (3b)12,16 was obtained by two different 
procedures, following the literature methods for analogous compounds.  
Procedure (1): Compound 3b was obtained from 150 mg (0.355mmol) of compound 1a,105 
mg (0.357mmol) of compound 2b and 31 mg (0.378mmol) of sodium acetate previously 
dissolved in 2 mL of MeOH and 25 mL of toluene as solvent. The mixture was firstly purged 
under nitrogen. In the same atmosphere the mixture was heated and stirred at 90 ºC for 48 
hours, using a magnetic stirrer equipped with a digital thermometer to control the temperature. 
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The obtained mixture was filtered, and the solvent was removed in a rotatory evaporator. The 
solid obtained was dissolved in 1 mL of 1:1 MeOH/CH2Cl2 and the solution was kept for 24 
hours in the freezer. The obtained precipitate was filtered and dried under vacuum. Yield: 52 mg 
(24%).  
Procedure (2): Compound 3b was obtained from 150 mg (0.355 mmol) of compound 1a, 
104 mg (0.354 mmol) of compound 2b and 32 mg (0.39 mmol) of sodium acetate previously 
dissolved in 25 mL of MeOH. The mixture was firstly purged in nitrogen atmosphere. In the 
same atmosphere the mixture was heated and stirred at 65 ºC for 48 hours, using a magnetic 
stirrer equipped with a digital thermometer to control the temperature. The obtained mixture was 
filtered, and the solvent was removed in a rotatory evaporator. The solid was dissolved in 1mL 
of CH2Cl2 and kept in the freezer for 24 hours. The obtained precipitated was filtered and dried 
under vacuum. Yield: 37 mg (17%). 
 
White solid. 3bA obtained using procedure (1) 
1H NMR (400 MHz, CDCl3) δ 8.25 [d, 4J (Hh-Hi’) = 2.0 Hz, 1Hh], 
8.18 [d, 3J (Hd-Hb) = 8.5 Hz, 1Hd], 7.89 [t, J (Ha,e-Hb) = 7.7 Hz, 
2Ha,e], 7.66 [d, 3J (Hc-Hb) = 7.2 Hz, 1Hc], 7.62 – 7.50 [m, 4Hb,j], 
6.99 [dd, 3J (Hi’-Hi) = 8.0, 4J (Hi’-Hh) = 1.9 Hz, 1Hi’], 6.90 [d, 3J (Hi-
Hi’) = 8.0 Hz, 1Hi], 6.76 [q, 3J (Hf-Hg) = 6.7 Hz, 1Hf], 3.67 [s,3 J 
(Hk-Pt) = 22.45 Hz, 3Hk], 3.66 [d, 3J (Hl-Pt) = 19.57 Hz, 3Hl],  1.90 
[d, 3J (Hg-Hf) = 6.7 Hz, 3Hg]. 
ESI – (+) {H2O:CH3CN (1:1)} m/z: 607.09 [M-Cl+CH3CN]+, 566.07 




[PtCl{(2,6-Cl2C6H3)CHNCH(CH3)C10H6}{SOMe2}] (3c)12,16 was obtained by two procedures.  
Procedure (1): Compound 3c was obtained from 151 mg (0.355 mmol) of compound 1a, 
116 mg (0.355 mmol) of compound 2c and 29 mg (0.355 mmol) of sodium acetate previously 
dissolved in 2 mL of MeOH and 25 mL of toluene as solvent. The mixture was firstly purged 
under nitrogen. In the same atmosphere the mixture was heated and stirred at 90 ºC for 48 
hours, using a magnetic stirrer equipped with a digital thermometer to control the temperature. 
The obtained mixture was filtered, and the solvent was removed in a rotatory evaporator. The 
solid obtained was dissolved in 1 mL of 1:1 MeOH/CH2Cl2 and the solution was kept for 24 
hours in the freezer. The obtained precipitate was filtered and dried under vacuum. Yield: 60 mg 
(28%).  
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Procedure (2): Compound 3c was obtained from 151 mg (0.355 mmol) of compound 1a, 
115 mg (0.354 mmol) of compound 2c, 31 mg (0.37 mmol) of sodium acetate previously 
dissolved in 25 mL of MeOH. The mixture was firstly purged in nitrogen atmosphere. In the 
same atmosphere the mixture was heated and stirred at 65 ºC for 48 hours, using a magnetic 
stirrer equipped with a digital thermometer to control the temperature. The obtained mixture was 
filtered, and the solvent was removed in a rotatory evaporator. The solid was dissolved in 1mL 
of CH2Cl2 and kept in the freezer for 24 hours. The obtained precipitated was filtered and dried 
under vacuum. Yield: 76 mg (34%). 
 
Orange solid. 3cBE Obtained using procedure (2) 
Major product: 
1H NMR (400 MHz, CDCl3) δ 9.47 [s, 3J(Hh-Pt) = 75.66, 
1Hh], 8.27 [d, 3J (He-Hd) = 8.7 Hz, 3J(He-Pt) = 67.0 Hz, 1He], 
7.96 – 7.72 [m, 2Ha,d], 7.59 [d, 3J (Hc-Hb) = 8.7 Hz, 1Hc], 
7.52 – 7.43 [m, 3Hi,j], 7.35 [m, 2Hb], 5.68 [q, 3J (Hf-Hg) = 6.4 
Hz, 3J (Hf-Pt) = 67.0 Hz, 1Hf], 3.68 [s, 3Hk], 3.65 [s, 3Hl], 
1.70 [d, J (Hg-Hf) = 6.4 Hz, 3Hg]. 
ESI – (+) {H2O:CH3CN (1:1)} m/z: 641.05 [M-Cl+CH3CN]+, 
600.02 [M-Cl]+. 
 
Additional compound obtained using procedure (1) 3cA’ 
ESI – (+) {H2O:CH3CN (1:1)} m/z: 697.14 [M+toluene-
2Cl+CH3CN]+, 656.11 [M+toluene-2Cl]+, 641.05 [M-
Cl+CH3CN]+, 600.02 [M-Cl]+. 
 
 
[PtCl{(C10H6)CHNCH(CH3)C10H7}{SOMe2}] (3d)12,16 was obtained by two procedures.  
Procedure (1): Compound 3d was obtained from 154 mg (0.364 mmol) of compound 1a, 
114 mg (0.368 mmol) of compound 2d and 29 mg (0.355 mmol) of sodium acetate previously 
dissolved in 2 mL of MeOH and 25 mL of toluene as dissolvent. The mixture was firstly purged 
under nitrogen. In the same atmosphere the mixture was heated and stirred at 90 ºC for 48 
hours, using a magnetic stirrer equipped with a digital thermometer to control the temperature. 
The obtained mixture was filtered, and the solvent was removed in a rotatory evaporator. The 
solid obtained was dissolved in 1 mL of 1:1 MeOH/CH2Cl2 and the solution was kept for 24 
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hours in the freezer. The obtained precipitate was filtered and dried under vacuum. Yield: 53 mg 
(27%). 
Procedure (2): Compound 3d was obtained from 154 mg (0.364 mmol) of compound 1a, 
115 mg (0.372 mmol) of compound 2d and 33 mg (0.40 mmol) of sodium acetate previously 
dissolved in 25 mL of MeOH. The mixture was firstly purged in nitrogen atmosphere. In the 
same atmosphere the mixture was heated and stirred at 65 ºC for 48 hours, using a magnetic 
stirrer equipped with a digital thermometer to control the temperature. The obtained mixture was 
filtered, and the solvent was removed in a rotatory evaporator. The obtained solid was dissolved 
in 1mL of CH2Cl2 and kept in the freezer for 24 hours. The obtained precipitated was filtered and 




Major compound using procedure (1) (3dBE): 
1H NMR (400 MHz, CDCl3) δ 8.94 [d, 3J (Hd-Hb) = 7.2 Hz, 
1Hd], 8.63 [d, 3J (He-Hb) = 8.9 Hz, 2He,h], 6.31 [q, 3J (Hf-Hg) 
= 6.4 Hz, 1Hf], 3.28 [s, 3Hn], 3.26 [s, 3Ho], 2.54 [d, 3J (Hg-Hf) 
= 7.0 Hz, 3Hg]. 
ESI – (+) {H2O:CH3CN (1:1)} m/z: 671.10 [M+HCl+NH4]+, 




Major compound using procedure (2) (3dBZ): 
1H NMR (400 MHz, CDCl3) δ 9.98 [s, 1Hh], 6.86 [q, 3J (Hf-
Hg) = 6.7 Hz, 1Hf], 3.75 – 3.67 [m, 6Hn,o], 3.58 – 3.43 [m, 
3Hg] . 
ESI – (+) {H2O:CH3CN (1:1)} m/z: 1329.13 2M+2Cl+Na]+, 
676.06 [M+HCl+Na]+, 671.10 [M+HCl+NH4] +, 622.15 [M-
Cl+CH3CN]+, 618.10 [M+H] +, 581.12 [M-Cl] +, 544.14 [M-Cl-
DMSO+CH3CN]+. 
 
6.3.3. Preparation of triphenylphosphane compounds 
[PtCl{NH2CH(CH3)C10H6}{PPh3}] (4a)12,16 was obtained from 19 mg (0.040 mmol) of 
compound 3a and 11 mg (0.042 mmol) of triphenylphosphane which were allowed to react in 
acetone at room temperature for 2 hours. The solvent was removed with a rotatory evaporator 
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and a white solid was obtained. The solid was washed with diethyl ether, dried under vacuum 
and recrystallized in 1 mL of 1:1 MeOH/CH2Cl2. The solution was kept for 24 hours in the 
freezer. The precipitate obtained was filtered and dried under vacuum. Yield: 8 mg (29%). 
 
1H NMR (400 MHz, CDCl3) δ 7.81 – 7.72 [m, 4Hb,d,e], 7.68 [d, 
3J(Ha-Hb) = 8.3 Hz, 1Ha], 7.58 [d, 3J(Hc-Hb) = 8.2 Hz, 1Hc], 7.44 – 
7.28 [m, 15Hi], 6.89 [d, 3J (Hh-Hh’) = 8.6 Hz, 1Hh], 6.73 [dd, 2J (Hh’-
Hh) = 8.6, 3J (Hh’-Hf) = 2.9 Hz, 1Hh’], 5.47 [q, 3J(Hf-Hg) = 6.5 Hz,  
1Hf], 1.92 [d, eJ (Hg-Hf) = 6.4 Hz, 3Hg]. 
31P-{1H}-NMR (161.95 MHz, CDCl3) δ 23.20 [s, 1J (P-Pt) = 
4336.95 Hz, P] 
ESI – (+) {H2O:CH3CN (1:1)} m/z: 668.18 [M-Cl+CH3CN]+, 627.15 
[M-Cl]+, 279.09 [PPh3O]+. 
 
 
[PtCl{NH2CH(CH3)C10H6}{PPh3}] (4a’)12,16 was obtained from 19 mg (0.040 mmol) of 
compound 3a and 30 mg (0.11mmol) of triphenylphosphane which were allowed to react in 
acetone at room temperature for 2 hours. The solvent was removed with a rotatory evaporator 
and a white solid was obtained. The solid was washed with diethyl ether, dried under vacuum 
and recrystallized in 1 mL of 1:1 MeOH/CH2Cl2. The solution was kept for 24 hours in the 
freezer. The precipitate obtained was filtered and dried under vacuum.  
 
31P-{1H}-NMR (161.95 MHz, CDCl3) δ 23.54 [d, 2J 
(P1-P2)= 18.15 Hz, 1J (P1-Pt) = 1809.06 Hz, P1], 
21.36 [d, 2J (P2-P1) = 18.36 Hz, 1J (P2-Pt) = 
3806.30 Hz, P2]. 
ESI – (+) {H2O:CH3CN (1:1)} m/z: 668.18 [M-
Cl+CH3CN]+, 627.15 [M-Cl]+, 279.09 [PPh3O]+. 
 
 
[PtCl{(4-ClC6H3)CHNCH(CH3)C10H7}{PPh3}] (4b)12,16 was obtained from 60 mg (0.10 mmol) 
of compound 3b and 26 mg (0.099 mmol) of triphenylphosphane which were allowed to react in 
acetone at room temperature for 2 hours. The solvent was removed with a rotatory evaporator 
and a white solid was obtained. The solid was washed with diethyl ether, dried under vacuum 
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and recrystallized in 1 mL of 1:1 MeOH/CH2Cl2. The solution was kept for 24 hours in the 
freezer. The precipitate obtained was filtered and dried under vacuum. Yield: 29 mg (37%). 
 
31P-{1H}-NMR (161.95 MHz, CDCl3) δ 23.20 [s, 1J (P-Pt) = 
4332.85 Hz, P],  
 
 
[PtCl{(2,6-Cl2C6H3)CHNCH(CH3)C10H6}{PPh3}] (4c)12,16 was obtained from 17 mg (0.0.27 
mmol) of compound 3c and 26 mg (0.030 mmol) of triphenylphosphane which were allowed to 
react in acetone at room temperature for 2 hours. The solvent was removed with a rotatory 
evaporator and a white solid was obtained. The solid was washed with diethyl ether, dried under 
vacuum and recrystallized in 1 mL of 1:1 MeOH/CH2Cl2. The solution was kept for 24 hours in 
the freezer. The precipitate obtained was filtered and dried under vacuum. Yield: 13 mg (59%). 
 
1H NMR (400 MHz, CDCl3) δ 9.73 (d, J = 1.2 Hz, 1H), 5.84 [q, 3J(Hf-
Hg) = 6.5 Hz, 1Hf], 1.79 (d, J (Hg-Hf)= 6.4 Hz, 3Hg). 
 
31P-{1H}-NMR (161.95 MHz, CDCl3) δ 21.83 [s, 1J (P-Pt) = 4340.26 
Hz, P], 14.29. 
ESI – (+) {H2O:CH3CN (1:1)} m/z: 825.13 [M-Cl+CH3CN]+, 784.10 
[M-Cl]+. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
 
[PtCl{(C10H6)CHNCH(CH3)C10H7}{PPh3}] (4d)12,16 was obtained from 12 mg (0.019 mmol) 
of compound 3d and 9 mg (0.034 mmol) of triphenylphosphane which were allowed to react in 
acetone at room temperature for 2 hours. The solvent was removed by rotatory evaporator and 
a yellow solid was obtained. The solid was washed with diethyl ether and dried under vacuum 
and recrystallized in 1 mL of 1:1 MeOH/CH2Cl2. The solution was kept for 24 hours in the 
freezer. The obtained precipitate was filtered and dried under vacuum.  




The reactions of three imine ligands RCHNCH(CH3)C10H7 with cis-[PtCl2{(SO(Me)2}2] were 
studied using two different solvents (methanol or toluene) into the conditions previously reported 
for the corresponding amine C10H7CH(CH3)NH2. 
These reactions lead to complex mixtures of cyclometallated platinum compounds that were 
analyzed by 1H-NMR and mass spectrometry. 
For the less bulky imine 2b (R = 4-ClC6H4), the hydrolysis of the imine takes places easily 
under the reaction conditions, but by using high quality toluene, the endo-platinacycle could be 
obtained with a fair yield. 
For imine 2c (R = 2,6-Cl2C6H3) an exo-platinacycle was obtained in a fair yield in methanol, 
while in toluene a more complex mixture was obtained due to the formation of seven-membered 
metallacycles arising from the toluene insertion. 
The reactions of the imine 2d (R = 1-C10H7) gave mixtures of E and Z exo-platinacycles in 
ratios depending on the solvent used. 
The reactions of the obtained compounds with triphenylphosphane gave the corresponding 
derivatives from 3b and 3c, along with a certain amount of [PtCl2(PPh3)2] while only 
decomposition products were obtained for 3d, which suggest a lower stability of these exo-
platinacycles. 
To sum up, the best conditions to carry out these reactions have been elucidated, in 
particular the endo-platinocycle 3b is best obtained in toluene while the exo-platinocycle 3c is 
best obtained in methanol. 
Due to the presence of minor isomers in all cases, further purification of these compounds 
would be needed before testing them as possible anti-cancer agents. 
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9. ACRONYMS 
CCiTUB: Centres Científics i Tecnològics de la Universitat de Barcelona 
DMSO: dimethylsulfoxide 
DNA: deoxyribonucleic acid 
d: doublet 
dd: doublet of doublets 
ESI (+): electrospray mass spectrometry 
nJ(A-B): coupling constants with n bonds, between A and B atoms 
LC/MSD-TOF: liquid chromatography coupled to mass spectroscopy detector with time of 
flight as analyser 
m: multiplet 
Me: methyl 
MS: mass spectrometry 






δ: chemical shift 
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APPENDIX 13:  
1H-NMR and 31P-NMR spectra of 4c in CDCl3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
